These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36655374)

  • 1. Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate.
    Mahdy WYB; Yamamoto K; Ito T; Fujiwara N; Fujioka K; Horai T; Otsuka I; Imafuku H; Omura T; Iijima K; Yano I
    Clin Transl Sci; 2023 Apr; 16(4):618-630. PubMed ID: 36655374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach.
    Kneller LA; Hempel G
    Pharm Res; 2020 May; 37(6):110. PubMed ID: 32476097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes.
    Kneller LA; Abad-Santos F; Hempel G
    Clin Pharmacokinet; 2020 Jan; 59(1):51-65. PubMed ID: 31359271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
    Abduljalil K; Pansari A; Jamei M
    J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.
    Wong YC; Centanni M; de Lange ECM
    J Clin Pharmacol; 2019 May; 59(5):731-747. PubMed ID: 30676661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Verification of a Linked
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1.
    Yoo HD; Cho HY; Lee SN; Yoon H; Lee YB
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):329-41. PubMed ID: 22623266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach.
    Li S; Xie F
    Br J Clin Pharmacol; 2023 Apr; 89(4):1402-1412. PubMed ID: 36357171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations.
    Abduljalil K; Gardner I; Jamei M
    Front Pediatr; 2022; 10():840710. PubMed ID: 35652056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.
    Vermeulen A; Piotrovsky V; Ludwig EA
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):183-206. PubMed ID: 17136449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data.
    Samtani MN; Gopal S; Gassmann-Mayer C; Alphs L; Palumbo JM
    CNS Drugs; 2011 Oct; 25(10):829-45. PubMed ID: 21936586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.
    Gaohua L; Abduljalil K; Jamei M; Johnson TN; Rostami-Hodjegan A
    Br J Clin Pharmacol; 2012 Nov; 74(5):873-85. PubMed ID: 22725721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Brexpiprazole, Quetiapine, Risperidone, and Its Active Metabolite Paliperidone in a Postpartum Woman and Her Baby.
    Konishi T; Kitahiro Y; Fujiwara N; Yamamoto K; Hashimoto M; Ito T; Itohara K; Fujioka K; Imafuku H; Otsuka I; Omura T; Yano I
    Ther Drug Monit; 2024 Oct; 46(5):687-691. PubMed ID: 38648649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population.
    Abduljalil K; Gardner I; Jamei M
    Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic assessment of alprazolam-induced neonatal abstinence syndrome using physiologically based pharmacokinetic model.
    Yamamoto K; Fukushima S; Mishima Y; Hashimoto M; Yamakawa K; Fujioka K; Iijima K; Yano I
    Drug Metab Pharmacokinet; 2019 Dec; 34(6):400-402. PubMed ID: 31699653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBPK/PD Modeling of Nifedipine for Precision Medicine in Pregnant Women: Enhancing Clinical Decision-Making for Optimal Drug Therapy.
    Liu X; Wang W; Chen J; Chen D; Tao Y; Ouyang D
    Pharm Res; 2024 Jan; 41(1):63-75. PubMed ID: 38049651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.
    Vandenberghe F; Guidi M; Choong E; von Gunten A; Conus P; Csajka C; Eap CB
    Clin Pharmacokinet; 2015 Dec; 54(12):1259-72. PubMed ID: 26129906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.
    Polasek TM; Tucker GT; Sorich MJ; Wiese MD; Mohan T; Rostami-Hodjegan A; Korprasertthaworn P; Perera V; Rowland A
    Br J Clin Pharmacol; 2018 Mar; 84(3):462-476. PubMed ID: 29194718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability.
    Citrome L
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):873-88. PubMed ID: 22632481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.